M&A Corner
AxoSim Enters into a Definitive Agreement to Acquire Vyant Bio’s StemoniX Assets.25 Jul 2023
AxoSim Technologies and Vyant Bio have entered a definitive agreement for AxoSim to acquire the microBrain™-associated assets of Vyant Bio’s... Continue Reading
|
Travere Therapeutics Enters Agreement to Sell its Bile Acid Product Portfolio for the Treatment of Rare Liver Diseases to Mirum Pharmaceuticals25 Jul 2023
Travere Therapeutics and Mirum Pharmaceuticals have reached a definitive agreement for the sale of Travere’s bile acid product portfolio, including... Continue Reading
|
Signant Acquires DSG to Enhance Its eClinical Solution Suite for Traditional and Decentralized Clinical Trials.25 Jul 2023
Signant Health, a leader in evidence generation for clinical trials, has acquired DSG, a leading provider of electronic data capture... Continue Reading
|
Eli Lilly To Acquire Versanis Bio17 Jul 2023
Eli Lilly is set to acquire Versanis Bio, a clinical-stage biopharmaceutical company specializing in cardiometabolic diseases. The deal includes an... Continue Reading
|
Korro Bio and Frequency Therapeutics Announce Merger Agreement17 Jul 2023
Korro Bio and Frequency Therapeutics have entered into a definitive merger agreement to combine their companies in an all-stock transaction.... Continue Reading
|
Galmed Pharmaceuticals Announces Pricing of $7 Million Public Offering17 Jul 2023
Galmed Pharmaceuticals has entered into securities purchase agreements with two institutional investors for the sale of 5.6 million ordinary shares... Continue Reading
|
Acadia Pharmaceuticals Acquires Ex-North American Rights to Trofinetide and Global Rights to Neuren’s NNZ-2591 in Rett Syndrome and Fragile X Syndrome.17 Jul 2023
Acadia Pharmaceuticals has expanded its licensing agreement with Neuren Pharmaceuticals to acquire global rights to NNZ-2591, a development candidate for... Continue Reading
|
Revelation Pharma Completes Two Acquisitions17 Jul 2023
Private equity firm Osceola Capital has announced the acquisition of two pharmacies, Eagle Pharmacy and Lee Silsby Compounding Pharmacy, by... Continue Reading
|
Applied DNA Acquires RNA Polymerase Developer Spindle Biotech, Launches LineaIVT(TM) Platform to Substantially Improve mRNA Manufacturing and Broaden Market Reach.17 Jul 2023
Applied DNA Sciences has acquired Spindle Biotech, an early-stage biotech company specializing in RNA manufacturing technologies. The acquisition combines Applied... Continue Reading
|
ExoCoBio, A Leader in Exosome Technology, Completes the Acquisition of BENEV, a Global Medical Aesthetic Brand17 Jul 2023
ExoCoBio has completed the acquisition of a majority ownership in BENEV, a global medical aesthetic company. BENEV is known for... Continue Reading
|